A Novel Nutrient Intervention of Probiotics, Glutamine, and Fish Oil in Psychological Distress: A Concurrent Multiple Baseline Design.
Sandra GraceJoanne F BradburyCathy AvilaLiza TwohillSamantha Morgan-BasnettPublished in: Journal of integrative and complementary medicine (2023)
Objectives: The aim of this study was to investigate whether a combination of nutrients designed to promote gut and brain health also lowers psychological distress. The hypothesis is that a probiotic with fish oil, and glutamine supplement will reduce psychological distress. Design: A multiple baseline design was used to collect data from seven naturopathic patients in private naturopathic clinics in Australia. Patients were between 18 and 65 years of age, and had a Kessler-10 (K10) score between 16 and 30 and symptoms associated with mild gastrointestinal discomfort experienced several times most weeks for 3 months. They were randomized into one of three pathways to stagger the introduction of the intervention. Interventions: Participants received either a supplement incorporating a probiotic formulation (including Lactobacillus rhamnosus ), a glutamine powder formulation, and fish oil, or matched placebos. The primary outcome measure was psychological distress as measured by the K10 scale of psychological distress. Results: The data showed a general trend toward lower K10 scores during the active phase compared with the baseline phase, with a marked reduction in the variances between phases. After controlling for time and baseline values, no significant difference between the phases for the K10 and the Perceived Stress Scale was found, but there was still a significant reduction in symptoms on the Gastrointestinal Symptom Rating Scale. Conclusions: A combination of a probiotic formulation, a glutamine powder formulation, and fish oil did not affect psychological distress and perceived stress, but had a significant beneficial effect on gastrointestinal symptoms in patients with high distress and concurrent gut symptomology. Clinical Trial: ACTRN12620000928910.
Keyphrases
- sleep quality
- end stage renal disease
- clinical trial
- chronic kidney disease
- newly diagnosed
- physical activity
- ejection fraction
- mental health
- drug delivery
- healthcare
- randomized controlled trial
- double blind
- electronic health record
- peritoneal dialysis
- public health
- depressive symptoms
- fatty acid
- patient reported outcomes
- social support
- risk assessment
- squamous cell carcinoma
- big data
- study protocol
- bacillus subtilis
- patient reported
- phase iii
- subarachnoid hemorrhage
- phase ii
- brain injury
- social media
- cerebral ischemia
- stress induced